Tag:
NanoBio Corp.
Latest Headlines
Latest Headlines
NanoBio nabs $6M vax grant
NanoBio, a promising spinoff from the University of Michigan, nabbed a $6 million grant from the Gates Foundation for its work on a new nasal spray vaccine. NanoBio has been using its cutting edge
Intranasal vaccine to treat Hepatitis B
NanoBio Corporation and the University of Michigan’s, Michigan Nanotechnology Institute for Medicine and Biological Sciences will develop an intranasal vaccine for the treatment of hepatitis B
NanoBio inks $54.5M development deal with GSK
Ann Arbor, MI-based NanoBio has inked a deal with GlaxoSmithKline for an experimental cold sore therapy poised to go into late-stage testing. NanoBio picks up a $14.5 million upfront payment and
NanoBio tops up $22M round as it closes in on pact
NanoBio is announcing later this morning that it closed a $22 million Series B after its major shareholder, Perseus, and Venture Investors put up an additional $10 million. The money gives the Ann
Pulmatrix, NanoBio join swine flu battle
Big biotechs were given the genetic code for the swine flu (H1N1) this week, but a viable vaccine may be months away. Start-up biotechs Pulmatrix and NanoBio are developing anti-infectives that do
NanoBio raises $12M in second round
Ann Arbor-based NanoBio has raised $12 million in series B equity financing. Perseus led the round, with contributions from existing investors. The cash will be used to complete a Phase I study
NanoBio looks for Big Pharma partners
Crain's Detroit Business is reporting that NanoBio--a 2008 Fierce 15 company --is close to announcing an $11
